P318 Aerobika Oscillating PEP device for airway clearance therapy (ACT): an audit of clinical experience and patient reported outcomes (PRO) in cystic fibrosis (CF)

2020 ◽  
Vol 19 ◽  
pp. S144-S145
Author(s):  
B. Button ◽  
L.M. Wilson ◽  
M. Poulsen ◽  
J.W. Wilson
Keyword(s):  
Cystic Fibrosis ◽  
Clinical Experience ◽  
Patient Reported Outcomes ◽  
Airway Clearance ◽  
Patient Reported ◽  
Airway Clearance Therapy

scholarly journals Trajectories of Adherence to Airway Clearance Therapy for Patients with Cystic Fibrosis

2010 ◽  
Vol 35 (9) ◽  
pp. 1028-1037 ◽  
Author(s):  
A. C. Modi ◽  
A. E. Cassedy ◽  
A. L. Quittner ◽  
F. Accurso ◽  
M. Sontag ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Airway Clearance ◽  
Airway Clearance Therapy

scholarly journals Persistent Adherence to Airway Clearance Therapy in Adults With Cystic Fibrosis

2019 ◽  
Vol 64 (7) ◽  
pp. 778-785 ◽  
Author(s):  
Allen C Sherman ◽  
Stephanie Simonton-Atchley ◽  
Dianne Campbell ◽  
Raghu M Reddy ◽  
Catherine E O'Brien ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Airway Clearance ◽  
Airway Clearance Therapy

scholarly journals One Center's Guide to Outpatient Management of Pediatric Cystic Fibrosis Acute Pulmonary Exacerbation

2016 ◽  
Vol 10 ◽  
pp. CMPed.S38336 ◽  
Author(s):  
Corinne A. Muirhead ◽  
Julian N. Sanford ◽  
Benjamin G. Mccullar ◽  
Dawn Nolt ◽  
Kelvin D. Macdonald
Keyword(s):  
Cystic Fibrosis ◽  
Antimicrobial Agents ◽  
Inpatient Setting ◽  
Surveillance Culture ◽  
Pulmonary Exacerbation ◽  
Mucus Production ◽  
Airway Clearance ◽  
Chronic Disorder ◽  
Culture Activity ◽  
Airway Clearance Therapy

Cystic fibrosis (CF) is a chronic disorder characterized by acute pulmonary exacerbations that comprise increased cough, chest congestion, increased mucus production, shortness of breath, weight loss, and fatigue. Typically, severe episodes are treated in the inpatient setting and include intravenous antimicrobials, airway clearance therapy, and nutritional support. Children with less-severe findings can often be managed as outpatients with oral antimicrobials and increased airway clearance therapy at home without visiting the specialty CF center to begin treatment. Selection of specific antimicrobial agents is dependent on pathogens found in surveillance culture, activity of an agent in patients with CF, and the unique physiology of these patients. In this pediatric review, we present our practice for defining acute pulmonary exacerbation, deciding treatment location, initiating treatment either in-person or remotely, determining the frequency of airway clearance, selecting antimicrobial therapy, recommending timing for follow-up visit, and recognizing and managing treatment failures.

scholarly journals Do Patient-Reported Outcomes Have a Role in the Management of Patients with Cystic Fibrosis?

2012 ◽  
Vol 3 ◽  
Author(s):  
M. Sam Salek ◽  
S. Jones ◽  
M. Rezaie ◽  
C. Davies ◽  
R. Mills ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Patient Reported Outcomes ◽  
Patient Reported
Sign in / Sign up

Export Citation Format

Share Document